COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 2407: Articles 24061-24070  | Next

Comparative Evaluation of Three Serologic Assays for the Identification of SARS-CoV-2 Antibodies
Hogan, K. O., Klippel, D., Plapp, F. V., Liesman, R. M.
10.1101/2020.08.04.20167643 — Posted: 2020-08-05
Seroprevalence of COVID-19 in Niger State
Majiya, H., Aliyu-Paiko, M., Balogu, V. T., Musa, D. A., Salihu, I. M., Kawu, A. A., Bashir, I. Y., Sani, A. R., Baba, J., Muhammad, A. T., Jibril, F. L., Bala, E., Obaje, N. G., Aliyu, Y. B., Muhammad, R. G., Mohammed, H., Gimba, U. N., Uthman, A., Liman, H. M., Alhaji, S. A., James, J. K., Makusidi, M. M., Isah, M. D., Abdullahi, I., Ndagi, U., Waziri, B., Bisallah, C. I., Dadi-Mamud, N. J., Ibrahim, K., Adamu, A. K.
10.1101/2020.08.04.20168112 — Posted: 2020-08-05 Discussion: Onsite
Analysis of single nucleotide polymorphisms between 2019-nCoV genomes and its impact on codon usage
Gupta, S., Singh, R., Paul, P.
10.1101/2020.08.05.237404 — Posted: 2020-08-05
Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein (N protein) and its consequences
Rahman, M. S., Islam, M. R., Ul Alam, A. S. M. R., Islam, I., Hoque, M. N., Akter, S., Rahaman, M. M., Sultana, M., Hossain, M. A.
10.1101/2020.08.05.237339 — Posted: 2020-08-05
Rapid GMP-compliant expansion of SARS-CoV-2-specific T cells from convalescent donors for use as an allogeneic cell therapy for COVID-19
Cooper, R. S., Fraser, A. R., Smith, L., Burgoyne, P., Imlach, S. N., Jarvis, L. M., Zahara, S., Turner, M. L., Campbell, J. D.
10.1101/2020.08.05.237867 — Posted: 2020-08-05
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
Hoffmann, M., Hofmann-Winkler, H., Smith, J. C., Krueger, N., Sorensen, L. K., Sogaard, O. S., Hasselstrom, J. B., Winkler, M., Hempel, T., Raich, L., Olsson, S., Yamazoe, T., Yamatsuta, K., Mizuno, H., Ludwig, S., Noe, F., Sheltzer, J. M., Kjolby, M., Poehlmann, S.
10.1101/2020.08.05.237651 — Posted: 2020-08-05
Host metabolic reprogramming in response to SARS-Cov-2 infection
Moolamalla, S. T. R., Chauhan, R., Priyakumar, U. D., Vinod, P. K.
10.1101/2020.08.02.232645 — Posted: 2020-08-05 Discussion: Onsite | Offsite
Evaluating the impact of non-pharmaceutical interventions for SARS-CoV-2 on a global scale
Esra, R. T., Jamesion, L., Fox, M. P., Letswalo, D., Ngcobo, N., Mngadi, S., Estill, J. G., Meyer-Rath, G., Keiser, O.
10.1101/2020.07.30.20164939 — Posted: 2020-08-05
Hypertonic saline solution inhibits SARS-CoV-2 in vitro assay
Machado, R. R. G., Glaser, T., Araujo, D. B., Petiz, L. L., Oliveira, D. B. L., Durigon, G. S., Leal, A. L., Pinho, J. R. R., Ferreira, L. C. S., Ulrich, H., Durigon, E. L. R., Guzzo, C. R.
10.1101/2020.08.04.235549 — Posted: 2020-08-04
Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis
Bull, R. A., Adikari, T., Hammond, J. M., Stevanovski, I., Ferguson, J. M., Beukers, A. G., Naing, Z., Yeang, M., Verich, A., Gamaarachichi, H., Kim, K. W., Luciani, F., Stelzer-Braid, S., Eden, J.-S., Rawlinson, W. D., van Hal, S. J., Deveson, I. W.
10.1101/2020.08.04.236893 — Posted: 2020-08-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).